Category:
Active Pharmaceutical Ingredients
CAS NO:
NA
Standard:
In-house Standards,
Artemether + Lumefantrine suspension is a fixed-dose combination antimalarial therapy. It features nanosuspension technology for enhanced bioavailability of poorly soluble lumefantrine. The formulation combines artemisinin derivatives with long-acting partners to target Pfalciparum. Key identifiers include CAS 90608-79-4 (Artemether) and CAS 125026-76-6 (Lumefantrine).
Contraindicated in patients with known hypersensitivity to artemisinin or lumefantrine. Strictly store below 30°C away from direct sunlight. Monitor QT interval prolongation risks during co-administration with other cardiotoxic agents. Use only under professional medical supervision.